DXC Technology Company filings document operating results, segment reporting and capital-structure activity for its IT services business. Form 8-K reports furnish quarterly and fiscal results, investor call materials, Regulation FD updates and the company's reporting structure across Consulting & Engineering Services, Global Infrastructure Services and Insurance Services.
Other filings and exhibits record debt financing actions involving DXC Capital Funding DAC, senior note offerings, redemption notices, and NYSE Form 25 removal of listing and registration for the 1.750% Notes due 2026. The disclosures also cover common stock reporting, exhibit treatment and Exchange Act filing status.
DXC Technology executive vice president for GIS Christopher Drumgoole received a grant of 181,878 shares of common stock in the form of restricted stock units. The award carries no purchase price and is compensation-related, not an open‑market trade.
Each RSU converts into one DXC common share as it vests. The units will vest in three equal annual installments beginning May 12, 2027, spreading the benefit over several years. After this grant, Drumgoole directly holds 731,427 DXC shares, a figure that includes unvested RSUs.
DXC Technology Co President and CEO Raul J. Fernandez reported buying common stock in the open market. On May 11, 2026, he made two open-market purchases totaling 28,050.853 shares at prices of $9.0000 and $8.8950 per share.
After these transactions, his reported beneficial ownership rose to about 844,052 shares of DXC common stock, which the disclosure notes includes unvested Restricted Stock Units. The filing also corrects a prior rounding error by recognizing 0.147 fractional shares from an earlier 2021 acquisition.
DXC Technology Company files its Annual Report for the year ended March 31, 2026, describing a global IT services and software business focused on AI‑enabled transformation. The company operates through three segments: Consulting & Engineering Services, Global Infrastructure Services, and Insurance Software & Services, serving enterprises and public sector clients worldwide.
DXC highlights its Xponential framework, Core Track and Fast Track initiatives to embed AI, automation and data capabilities across offerings. The filing emphasizes ESG governance, Science Based Targets initiative‑validated emissions goals, data center consolidation, and a hybrid work model to reduce carbon emissions. Extensive risk disclosures cover sales execution, talent retention, AI deployment and regulation, cybersecurity, data privacy, complex global regulation, indebtedness, inflation, geopolitical tensions, climate change, and evolving ESG and AI laws that could materially affect results and the trading price of DXC common stock.
DXC Technology reported fourth-quarter fiscal 2026 revenue of $3.13 billion, down 1.2% year over year, and posted a GAAP net loss with diluted EPS of $(0.84). Adjusted EBIT margin was 7.6% and non-GAAP diluted EPS was $0.77. Free cash flow was $110 million for the quarter and $713 million for the full year on revenue of $12.64 billion and GAAP diluted EPS of $0.10. Bookings were $3.3 billion in Q4 and $12.4 billion for the year, with book-to-bill ratios of 1.07x and 0.98x. For fiscal 2027, the company guides to organic revenue decline of 5.0% to 3.0%, adjusted EBIT margin of 6.0% to 7.0%, non-GAAP EPS of $2.40 to $2.90, and free cash flow of about $600 million.
Del Bene Robert F reported acquisition or exercise transactions in this Form 4 filing.
DXC Technology executive vice president and chief financial officer Robert F. Del Bene received an award of 64,604 shares of common stock as part of his regular-cycle FY2024 performance-vesting restricted stock units. The grant was recorded at a price of $0.00 per share as equity compensation rather than an open-market purchase.
The PSUs were earned based on performance metrics measured over a three-year performance period and are scheduled to settle on or around May 23, 2026. Following this award, Del Bene directly holds 397,982 shares of DXC common stock, a figure that includes unvested restricted stock units.
Drumgoole Christopher reported acquisition or exercise transactions in this Form 4 filing.
DXC Technology Co reported that EVP, GIS Christopher Drumgoole received a grant of 85,194 shares of common stock on April 29, 2026, at no purchase price, as part of his equity compensation.
The award consists of regular-cycle FY2024 performance-vesting restricted stock units earned over a three-year performance period and scheduled to settle on or around May 23, 2026. After this grant, Drumgoole directly holds 549,549 shares of DXC common stock, a figure that includes unvested restricted stock units.
DXC Technology Co reported that Chief People Officer Jennifer Ragone received an award of 7,156 shares of common stock as a grant or other acquisition. These shares relate to regular-cycle FY2024 performance-vesting restricted stock units earned over a three-year performance period.
After this award, Ragone beneficially owns 104,216 shares of DXC common stock directly, and this figure includes unvested restricted stock units. The performance stock units are scheduled to settle on or around May 23, 2026, aligning payout with multi-year performance.
Voci Christopher Anthony reported acquisition or exercise transactions in this Form 4 filing.
DXC Technology senior vice president and controller Christopher Anthony Voci reported an award of 15,336 shares of common stock as a grant of performance-vesting restricted stock units. These FY2024 PSUs are earned over a three-year performance period and are scheduled to settle on or around May 23, 2026. After this award, Voci directly holds 98,542 shares of common stock, a figure that the disclosure notes includes unvested restricted stock units. This is a compensation-related equity grant rather than an open-market stock purchase.
August Raymond Alexander reported acquisition or exercise transactions in this Form 4 filing.
DXC Technology executive Raymond Alexander, President of Insurance Software & BPS, reported an equity award of 43,814 shares of Common Stock. The grant consists of FY2024 performance-vesting restricted stock units (PSUs) earned over a three-year performance period and scheduled to settle on or around May 23, 2026. There was no purchase price, reflecting compensation rather than an open-market buy. After this award, Alexander directly holds 371,946 shares of Common Stock, which the disclosure notes includes unvested restricted stock units.
American Century entities reported beneficial ownership stakes in DXC Technology Company Common Stock. The filing lists holdings as of 03/31/2026, showing American Century ETF Trust with 8,706,339 shares (5.1%) and American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research each with 9,074,619 shares (5.4%). The schedule identifies voting and dispositive power as sole for those holdings and states the filings were signed on 05/01/2026.